Press Releases

DAY HI:
DAY LOW:
VOLUME:

Copyright West LLC. Minimum 15 minutes delayed.

Press Releases

Date Title Format
Aug 22, 2002
NeoTherapeutics Announces Organizational Changes Designed to Bring On-Going Monthly Expenses Below $500,000 Changes solidify strategic commitment to anti-cancer drug development and out-licensing of neurology products IRVINE, Calif., Aug. 22 /PRNewswire-FirstCall/-- NeoTherapeutics, Inc.
Aug 21, 2002
NeoTherapeutics Announces New Financial Leadership IRVINE, Calif., Aug. 21 /PRNewswire-FirstCall/ -- NeoTherapeutics, Inc. (Nasdaq: NEOT ) announced today the retirement of Samuel Gulko, Senior Vice President, Finance; Chief Financial Officer; Secretary; and, Treasurer. Mr.
Aug 20, 2002
NeoTherapeutics Announces Major Strategic Restructuring Company to focus resources on development of phase 3 anti-cancer drug and licensing out anti-psychotic and attention deficit drugs IRVINE, Calif., Aug. 20 /PRNewswire-FirstCall/ -- NeoTherapeutics, Inc.
Aug 16, 2002
NeoTherapeutics Names Dr. Rajesh Shrotriya Chairman and Chief Executive Officer New CEO to assume duties immediately IRVINE, Calif., Aug. 16 /PRNewswire-FirstCall/ -- The Board of Directors of NeoTherapeutics, Inc. (Nasdaq: NEOT) announced today the appointment of Rajesh C. Shrotriya, M.D.
Displaying 781 - 784 of 784